Edit this postWhich Stocks and Global Cues Are Likely to Drive Market Action Today
About Today’s Brokerage and Macro Triggers
Markets are expected to react to a mix of stock-specific brokerage actions and supportive global macro cues. Updates from Goldman Sachs, Nuvama, and IIFL Fin point to selective opportunities, while Citi’s assessment of US inflation strengthens the case for a dovish Federal Reserve stance.
Healthcare, consumer durables, IT services, and BPO stocks are likely to remain in focus, alongside global sentiment driven by easing US inflation trends.
Key Brokerage Highlights
🔹 Goldman Sachs maintains a Buy on Max Healthcare with a target of ₹1,325.
🔹 Nuvama retains a Reduce rating on Voltas, cutting target to ₹1,170.
🔹 IIFL Fin initiates Buy on Firstsource with a target price of ₹420.
🔹 Citi flags softer-than-expected US core CPI, supporting a dovish Fed outlook.
Such mixed brokerage actions suggest a stock-picking environment rather than a broad-based directional move. Traders may therefore focus on company-specific triggers while tracking global liquidity cues through Nifty Tip for index-level alignment.
Stock-Specific Developments Snapshot
| Company | Broker View | Key Rationale |
|---|---|---|
| Max Healthcare | Goldman Sachs – Buy | Pune expansion via 450-bed hospital; ₹1,020 cr investment |
| Voltas | Nuvama – Reduce | Margin pressure from cost inflation; EPS cuts |
| Firstsource | IIFL Fin – Buy | Strong BPO turnaround; tech-driven UnBPO model |
Goldman Sachs remains constructive on Max Healthcare after the board approved acquisition of 100 percent equity in Yerawada Properties Pvt Ltd, enabling entry into the Pune market. The planned ~450-bed super specialty hospital, with a total investment of up to ₹1,020 crore, strengthens long-term growth visibility in a key healthcare cluster.
In contrast, Nuvama continues to remain cautious on Voltas, citing sustained cost inflation and margin pressure. Although management expects sequential improvement in Q3FY26, earnings estimates for FY26E and FY27E have been cut by 12 percent and 3 percent respectively.
|
Positive Drivers
🔹 Healthcare capacity expansion. 🔹 Strong BPO deal momentum. |
Near-Term Challenges
🔹 Margin pressure in consumer durables. 🔹 Earnings downgrades impacting sentiment. |
IIFL Fin’s initiation on Firstsource highlights a credible turnaround under the One Firstsource strategy. The company’s shift toward outcome-based pricing, stronger deal wins, and robust ACV growth position it well for sustained organic revenue and EPS CAGR over the medium term.
|
Opportunities
🔹 Stock-specific alpha from broker upgrades. 🔹 IT and BPO re-rating on deal momentum. |
Risks
🔹 Cost inflation impacting margins. 🔹 Volatility from global macro data. |
On the macro front, Citi’s analysis of US CPI shows core inflation undershooting expectations, with easing services and shelter inflation. Despite measurement noise, the overall trend supports a dovish Fed narrative, with Citi maintaining its base case of 75 basis points of rate cuts in 2025.
Investor Takeaway: Derivative Pro & Nifty Expert Gulshan Khera, CFP® believes the current environment favours selective stock picking backed by strong business execution and credible growth strategies. While global cues are turning supportive, disciplined positioning and focus on fundamentals remain key. Such market insights are regularly tracked at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.
